Missense mutations of RUNX1 were reported in luminal-type breast cancer [8], and loss-of-function somatic mutations or deletion of RUNX1 have been reported in breast cancer and lung cancer [9,10]. This evidence concerns the gene RUNX1 and lung carcinoma.